Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01586858 · ClinicalTrials.gov registry record
Rituximab for ANCA-associated Vasculitis (RAVE) Long-Term Follow-Up Study
A clinical trial, sponsored by Johns Hopkins University.
- Terminated
- Registry status
- 67
- Enrollment target
NCT01586858: Clinical Trial study, sponsored by Johns Hopkins University.
NCT01586858 is a clinical trial that was terminated before completion, run by Johns Hopkins University. The registered enrollment target is 67 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01586858 was terminated before completion, sponsored by Johns Hopkins University.
- TERMINATED
- Registry status
- 67 participants
- Enrollment target
Study Summary
Rituximab is the first drug approved by the United States Food and Drug Administration (FDA) for the treatment of patients with granulomatosis with polyangiitis (Wegener's granulomatosis) or microscopic polyangiitis. Because it is a relatively new medication, the long-term safety and efficacy of this drug is not yet clear. This study proposes to follow patients who were enrolled in the RAVE study to determine if treatment with rituximab influences long-term outcomes.
Primary Outcome
To determine the long-term safety of rituximab for the treatment of ANCA-associated vasculitis (granulomatosis with polyangiitis (Wegener's granulomatosis) and microscopic polyangiitis).
Interventions
- OTHER Observational
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2012-05 |
| Est. Completion | 2014-05-15 |
Why NCT01586858 stopped before completion
NCT01586858 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 67 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Observational is the first listed.
NCT01586858 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01586858 about?
NCT01586858 is a clinical study titled "Rituximab for ANCA-associated Vasculitis (RAVE) Long-Term Follow-Up Study". Rituximab is the first drug approved by the United States Food and Drug Administration (FDA) for the treatment of patients with granulomatosis with polyangiitis (Wegener's granulomatosis) or microscopic polyangiitis. Because it is a relatively new medication, the long-term safety and efficacy of thi...
What is the current status of trial NCT01586858?
This trial is currently terminated. The enrollment target is 67 participants. The study started on 2012-05. Estimated completion is 2014-05-15.
What interventions are being tested in trial NCT01586858?
The interventions under investigation include: Observational (OTHER).
Who is sponsoring clinical trial NCT01586858?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03213002 · 67 participants · Phase 1
Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM
- NCT04115163 · 67 participants · Phase 2
Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer
- NCT04315324 · 67 participants · Phase 1
Study to Test OBI-3424 in Patients With T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LBL)
- NCT04532424 · 67 participants · NA
Transcranial Magnetic Stimulation for Restricted and Repetitive Behavior in ASD
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia